InfoJustice Eds. | infojustice

Global Innovation Index 2019: India Makes Major Gains as Switzerland, Sweden, US, Netherlands, U.K. Top Ranking; Trade Protectionism Poses Risks for Future Innovation

Posted by InfoJustice Eds. | Jul 24, 2019 | Empirical Research

[World Intellectual Property Organization] Now in its 12th edition, the GII is a global benchmark that helps policy makers better understand how to stimulate and measure innovative activity, a main driver of economic and social development. The GII 2019 ranks 129 economies based on 80 indicators, from traditional measurements like research and development investments and international patent and trademark applications to newer indicators including mobile-phone app creation and high-tech exports.

UN Human Rights Council: Access to Medicines Fundamental to Enjoyment of Health

Posted by InfoJustice Eds. | Jul 16, 2019 | Multilateral Fora

Access to medicines and vaccines is one of the fundamental elements for the full realization of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health and the correspondent objectives of universal health coverage and health for all without discrimination, with special attention to reaching those furthest behind first

Liability for User-Generated Content Online: Principles for Lawmakers

Posted by InfoJustice Eds. | Jul 12, 2019 | Domestic Policies

[Joint statement endorsed by 28 civil society groups and 53 individuals] Policymakers have expressed concern about both harmful online speech and the content moderation practices of tech companies. Section 230, enacted as part of the bipartisan Communications Decency Act of 1996, says that Internet services, or “intermediaries,” are not liable for illegal third-party content except with respect to intellectual property, federal criminal prosecutions, communications privacy (ECPA), and sex trafficking (FOSTA). Of course, Internet services remain responsible for content they themselves create.

Letter from 104 Members of Congress to USTR, re: Data Protection for Biologics in NAFTA 2.0

Posted by InfoJustice Eds. | Jul 12, 2019 | NAFTA

We write to express our strong opposition to provisions that limit access to medicines in the revised NAFTA agreement, also known as United States-Mexico Canada Agreement (USMCA)…. The USMCA would keep drug prices out of reach for patients by increasing and locking in 10 years of marketing exclusivity for brand biologics, expanding the scope of brand biologics eligible for protection, and making it easier for brand-name drug companies to extend their monopolies through additional patents, patent extensions and other forms of patent “evergreening.”

Author: InfoJustice Eds.

Global Innovation Index 2019: India Makes Major Gains as Switzerland, Sweden, US, Netherlands, U.K. Top Ranking; Trade Protectionism Poses Risks for Future Innovation

UN Human Rights Council: Access to Medicines Fundamental to Enjoyment of Health

Liability for User-Generated Content Online: Principles for Lawmakers

Letter from 104 Members of Congress to USTR, re: Data Protection for Biologics in NAFTA 2.0

Search

Follow

PIJIP

Infojustice Roundup

Free to Share

Blog Categories

Comments on:

Civil Society Documents

Comments on:

industry | infojustice